IMF TV

From our weekly series “Ask Dr. Durie” to comprehensive news from key cancer medical conferences around the world, IMF-TV is your all-access ticket to critical myeloma research, patient education and guidance. Check back often for regularly updated content. 

Jan
12
Best of ASH 2016
Dr. Brian G.M. Durie discusses key takeaways from the annual conference and explains how this new and important information relates to myeloma patients, caregivers, and other members of the myeloma(...)
Jan
12
After relapse on CyBorD, what options are recommended?
In this video, Dr. Brian Duries shares different treatment options that may be available to a myeloma patient for whom CyBorD has not been effective.
Jan
05
What were some of the key takeaways from ASH 2016 for patients?
In this week’s video, Dr. Brian Durie identifies key takeaways for myeloma patients from the ASH 2016 abstracts. BOTTOM LINE: Look for ASH abstract summaries at myeloma.org, in the upcoming Myeloma(...)
Dec
15
Are tandem stem cell transplants necessary?
In this week’s video, Dr. Brian Durie provides results of the staMINA trial.
Dec
08
Is MGUS always asymptomatic?
In this week’s video, Dr. Brian Durie explains that even though MGUS is benign, some MGUS patients may develop symptoms due to the presence of abnormal monoclonal protein in the blood.
Dec
07
ASH 2016: MRD Burden Following ASCT in Multiple Myeloma
The immune system plays an essential role in both promoting and inhibiting the growth of MM. Loss of anti-myeloma immunity involves altered activation and polarization of effector cells as well as(...)